全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1346604-70-3 | Candesartan-d4 | C24H16D4N6O3 |
| 1346669-48-4 | 9-[1,1'-biphenyl]-4-yl-3,3'-bi-9H-carbazole;3-(9H-carbazol-3-yl)-9-(4-phenylphenyl)carbazole | C36H24N2 |
| 1346674-23-4 | 3,4,7,8-Tetrahydro-7,7-dimethyl-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one;4,4-Dimethyl-1,10-diazatricyclo[6.4.0.0(2,6)]dodeca-2(6),7-dien-9-one | C12H16N2O |
| 1346688-54-7 | 2,6-Dibromo-4-octyl-4H-dithieno[3,2-b:2',3'-d]pyrrole | C16H19Br2NS2 |
| 1346702-53-1 | Methyl 6-bromo-2-(1-methylethyl)-2H-indazole-4-carboxylate | C12H13BrN2O2 |
| 1346704-33-3 | 1-(1-Methylethyl)-N-[(6-methyl-2-oxo-4-propyl-1,2-dihydro-3-pyridinyl)methyl]-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide | C31H39N7O2 |
| 1346747-38-3 | Fingolimod-d<sub>4</sub>;2-Amino-1,1,3,3-tetradeuterio-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol | C19H29D4NO2 |
| 1346747-65-6 | N-Methyl valacyclovir;2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-3-methyl-2-(methylamino)butanoate | C14H22N6O4 |
| 1346747-69-0 | N-Ethyl valacyclovir;Valaciclovir impurity D;2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-(ethylamino)-3-methylbutanoate | C15H24N6O4 |
| 1346792-67-3 | 9-[3-(9H-Carbazol-9-yl)phenyl]-3-[4-(1-phenyl-1H-benzimidazol-2-yl)phenyl]-9H-carbazole | C49H32N4 |
| 1346808-41-0 | 5-Methylisoxazole-4-boronic acid pinacol ester;5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoxazole | C10H16BNO3 |
| 1346809-61-7 | 3-bromo-5H-pyrrolo[3,4-b]pyridin-7(6H)-one | C7H5BrN2O |
| 1347736-74-6 | 4,7-Dibromo-5-fluoro-2,1,3-benzothiadiazole;4,7-Dibromo-5-fluorobenzo[c][1,2,5]thiadiazole | C6HBr2FN2S |
| 1347750-75-7 | 5,8,11-Trioxa-2-azatetradecanedioic acid 1-(1,1-dimethylethyl) ester | C14H27NO7 |
| 1348664-75-4 | alpha-(2-Fluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol | C13H13FN6O |
| 1349151-98-9 | 1-Isopropyl-6-oxo-1,6-dihydropyridine-3-boronic acid pinacol ester;1-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1H)-one | C14H22BNO3 |
| 1349171-28-3 | 2-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyridine | C17H20BNO2 |
| 1349199-61-6 | Tert-butyl 3-oxo-1-oxa-6-azaspiro[3.3]heptane-6-carboxylate | |
| 1349199-63-8 | Tert-butyl 3-hydroxy-1-oxa-6-azaspiro[3.3]heptane-6-carboxylate | |
| 1349708-91-3 | 4-Bromo-5-chloro-2-fluorobenzoic acid | C7H3BrClFO2 |
| 1349715-77-0 | [(2-Fluorophenyl)methyl]hydrazine hydrochloride (1:2) | C7H9FN2.2(HCl) |
| 1349718-54-2 | 3,4-Dichloro-2-fluorobenzaldehyde | C7H3Cl2FO |
| 1349718-98-4 | 2,4-Dichloro-6-fluorobenzonitrile | C7H2Cl2FN |
| 1349723-93-8 | Elacestrant dihydrochloride;(6R)-6-[2-[Ethyl[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydro-2-naphthalenol hydrochloride (1:2); Elacestrant hydrochloride; RAD 901 dihydrochloride | C30H38N2O2 .2ClH |
| 1349796-36-6 | N-[4-[[[3-[(3,5-Dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methylbenzamide | C31H29N5O6S |
| 1350323-88-4 | 5-Methoxy-1-methyl-1H-pyrazole | C5H8N2O |
| 1350377-66-0 | 3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | C13H20BNO3 |
| 1350514-68-9 | Grazoprevir;(1R,2S)-N-[[[(1R,2R)-2-[5-(3-Hydroxy-6-methoxy-2-quinoxalinyl)pentyl]cyclopropyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide cyclic (1→2)-ether; ; MK 5172 | C38H50N6O9S |
| 1350543-95-1 | 3-Methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridazine | C11H17BN2O2 |
| 1350547-65-7 | UNC569;1-[(4-aminocyclohexyl)methyl]-N-butyl-3-(4-fluorophenyl)pyrazolo[3,4-d]pyrimidin-6-amine | C22H29FN6 |
| 1350549-36-8 | UNC 1025;4-[6-(butylamino)-3-(4-morpholin-4-ylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]cyclohexan-1-ol | C25H34N6O4S |
| 1350622-33-1 | 9-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1,2,3,4-tetrahydro-5H-[1]benzopyrano[3,4-b]pyridin-5-one | C18H25NO3Si |
| 1350643-72-9 | 3-[(1S)-1-Aminoethyl]-8-chloro-2-phenyl-1(2H)-isoquinolinone | C17H15ClN2O |
| 1350653-20-1 | Vericiguat;methyl N-[4,6-diamino-2-[5-fluoro-1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]carbamate | C19H16F2N8O2 |
| 1350734-61-0 | 2-Amino-1,5-anhydro-2,4-dideoxy-D-threo-pentitol | C5H11NO2 |
| 1350746-42-7 | 1-Bromo-cyclopropanecarbonitrile | C4H4BrN |
| 1350827-92-7 | 5-[(Hexahydro-4-hydroxy-1H-1,4-diazepin-1-yl)sulfonyl]isoquinoline | C14H17N3O3S |
| 1350884-56-8 | (18bR)-17-Fluoro-1,2,3,11,12,13,14,18b-octahydro-12-methyl-10H-5,7-ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-10-one | C20H21FN6O |
| 1350920-22-7 | N-Methyl-N-(phenylmethyl)-1-[[4-(trifluoromethyl)phenyl]methyl]-3-piperidinecarboxamide | C22H25F3N2O |
| 1350960-66-5 | 1-[3-[(4-Bromophenyl)sulfonyl]-2-quinoxalinyl]-4-piperidinol | C19H18BrN3O3S |
| 1351185-56-2 | 2-Fluoro-4-iodo-N-methylbenzamide | C8H7FINO |
| 1351403-03-6 | 2-Iodo-3-methoxy-6-methyl-2',4',6'-tris(1-methylethyl)-1,1'-biphenyl | C23H31IO |
| 1351413-50-7 | B-(1,2-Dihydro-1-methyl-2-oxo-4-pyridinyl)boronic acid | C6H8BNO3 |
| 1351522-04-7 | N-[4-[[[[5-(1,1-Dimethylethyl)-3-isoxazolyl]amino]carbonyl]amino]phenyl]-5-[(1-ethyl-2,2,6,6-tetramethyl-4-piperidinyl)oxy]-2-pyridinecarboxamide;AC 710 | C31H42N6O4 |
| 1351611-14-7 | N-formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | C26H25N5O5 |
| 1351635-67-0 | 6-Amino-7,9-dihydro-9-[(3S)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-7-(4-phenoxyphenyl)-8H-purin-8-one | C25H24N6O3 |
| 1351636-18-4 | Tirabrutinib;6-amino-9-[(3R)-1-(2-butynoyl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one; ONO 4059 | C25H22N6O3 |
| 1351758-37-6 | (2R)-2-Hydroxy-3-(hydroxymethyl)-3-methyl-N-(3-oxo-4-phenylbutyl)butanamide;RR6 (vanin inhibitor) | C16H23NO4 |
| 1351758-81-0 | [4-[[5-Chloro-4-(methylamino)-2-pyrimidinyl]amino]-3-methoxyphenyl]-4-morpholinylmethanone | C17H20ClN5O3 |
| 1351761-44-8 | GNE 7915;[4-[[4-(Ethylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-2-fluoro-5-methoxyphenyl]-4-morpholinylmethanone | C19H21F4N5O3 |